Rocket Pharmaceuticals, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
RCKT, RCKTW on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Fifth Avenue, Suite 7530, New York, NY

Insiders trading volume in the past year

Rocket Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rtw Investments, Lp Director, Other*, 10%+ Owner $905M Sep 15, 2023
Gaurav Shah CEO, Director $25.4M -$1.01M -3.83% Aug 16, 2024
Gotham Makker Director $24.9M -$15.6M -38.5% Sep 26, 2024
Kinnari Patel President, Head of R&D and Chief Operating Officer $11.8M -$381K -3.12% Aug 16, 2024
Jonathan Schwartz Chief Medical & Gene Therapy Officer Exhibit 24: Power of Attorney $4.9M Mar 25, 2024
David P. Southwell Director $3.04M -$1.95M -39% Jun 13, 2024
Martin Wilson General Counsel $2.34M -$270K -10.4% Aug 16, 2024
Aaron Ondrey Chief Financial Officer $2.2M Apr 1, 2024
Mark Andrew White General Manager, Commercial Affairs $1.56M -$422K -21.3% Oct 31, 2024
John Militello Vice President of Finance, Treasurer, Principal Accounting Officer $1.12M -$580K -34.2% Oct 31, 2024
Carlos Garcia-Parada Chief Financial Officer $1.07M Feb 14, 2022
Keith Woods Director $360K Jun 13, 2024
Carsten Boess Director $360K Jun 13, 2024
Fady Ibraham Malik Director $360K Jun 13, 2024
Mikael Dolsten Director $346K Sep 9, 2024
Naveen Yalamanchi Director $104K Jun 13, 2024
Pedro P. Granadillo Director $70K Jun 13, 2024
Roderick Wong Director, 10%+ Owner $50K Jun 13, 2024
Elisabeth Bjork Director $9.13K Sep 26, 2024

Recent Insider Transactions by Companies or Individuals for Rocket Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.